Proton Pump Inhibitors and Cardiac Safety: Emerging Evidence Linking Cardiovascular Disease, Arrhythmias, and Mechanistic Pathways
Abstract
Proton pump inhibitors (PPIs) are globally prescribed medications long perceived as pharmacologically safe. However, emerging evidence challenges this, revealing a potential association between chronic PPI exposure and adverse cardiovascular outcomes, including arrhythmogenesis. This review synthesizes findings from large, robust epidemiologic cohorts (ARIC, UK Biobank, Danish registries, Women’s Health Initiative (WHI)), consistently demonstrating that long-term PPI use is associated with higher risks of myocardial infarction, stroke, heart failure, and malignant arrhythmias, including out-of-hospital cardiac arrest and atrial fibrillation. These associations exhibit clear duration and dose-response patterns and are not replicated with H2 -receptor antagonists, suggesting a PPI-specific pharmacologic effect. Arrhythmic outcomes, while clinically consequential, remain under-investigated. We place particular emphasis on their biological plausibility. Mechanistic evidence provides converging pathways, including TRPM6/7-mediated hypomagnesemia, direct blockade of the hERG potassium channel, oxidative stress-driven remodeling, sympathetic hyperinnervation, and nitric oxide signaling impairment. Collectively, these influence myocardial repolarization and autonomic tone, offering a cohesive framework linking PPIs to both arrhythmic and atherosclerotic risk. Agents such as pantoprazole, omeprazole, and lansoprazole are most consistently implicated. The potential role of confounding…
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.